Chrissy Buteas, President and CEO of the HealthCare Institute of New Jersey, has expressed concerns regarding the recent White House Executive Order on drug pricing. The order introduces a “Most Favored Nation” (MFN) approach to drug pricing.
Buteas stated, “This ‘most favored nation’ (MFN) proposal won’t favor American patients or New Jersey jobs. This idea takes parts of socialized healthcare from other countries and tries to fit them into America’s healthcare system. This is like putting regular gasoline into a diesel engine.”
She further elaborated on her position by highlighting the potential risks associated with adopting foreign healthcare models. According to Buteas, “We have the strongest, most robust, and most advanced healthcare system in the world. Putting that European gasoline into an American diesel engine would make it likely the whole thing breaks down.”
Buteas also emphasized the importance of maintaining America’s leadership in medical research and development. She remarked, “The world unfairly freeloads on the American R&D that delivers remarkable new treatments and cures for patients. Instead of importing failed socialized medicine policies, we should focus on forcing foreign countries to pay their fair share for the cutting-edge medical advances that America’s global leadership makes possible.”
